Biliary Carcinoma

8 registered clinical trials studyying Biliary Carcinoma.

Status	Trial	Sponsor	Phase
Unknown	A Clinical Trial of TQB3454 Tablets in Healthy Adult Subjects NCT06139367	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Phase 1
Active Not Recruiting	A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma. NCT05987358	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Phase 3
Unknown	RC-48 Combined With GLS-010 in HER2-overexpressed Patients With Previously Treated Unresectable Biliary Tract NCT05540483	The First Affiliated Hospital with Nanjing Medical University	N/A
Unknown	A Study to Investigate Apatinib Combined Capecitabine on Adjuvant Therapy of Biliary Carcinoma NCT03609489	First Affiliated Hospital of Guangxi Medical University	Phase 2
Completed	Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer NCT03225989	Lokon Pharma AB	Phase 1 / Phase 2
Completed	Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma NCT02631590	H. Lee Moffitt Cancer Center and Research Institute	Phase 2
Terminated	Clinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tr NCT01855724	Hellenic Cooperative Oncology Group	Phase 2
Completed	Panitumumab Plus Gemcitabine and Oxaliplatin (GEMOX)Versus GEMOX Alone to Treat Advanced Biliary Tract Adenoca NCT01389414	Prof. Massimo Aglietta	Phase 2